a b s t r a c tWe describe treatment of atrial flutter and electrical storm presenting as incessant ventricular tachycardia (VT) after implantation of a cardiac resynchronization therapy defibrillator (CRT-D) in a patient with dilated cardiomyopathy. No prior arrhythmic event had occurred. Our treatment strategy, including amiodarone administration, was guided in part by signal-averaged vector-projected 187-channel electrocardiogram (SAVP-ECG)-based risk stratification for ventricular arrhythmia. Corrected recovery time (RTc) dispersion and Tpeak-end dispersion were used to evaluate transmural dispersion of repolarization. RTc and Tpeak-end dispersion increased during the period of electrical storm. Values were improved 2 years after CRT-D implantation, and the amiodarone was discontinued. The VT has not recurred despite discontinuation of the antiarrhythmic agent. SAVP-ECG-based risk stratification for ventricular arrhythmia proved useful for the management of antiarrhythmic therapy.A 77-year-old man with dilated cardiomyopathy visited our hospital in December 2010 and reported dyspnea on effort. Echocardiography revealed cardiac dyssynchrony with a low ejection fraction of 29%, and the patient was diagnosed with New York Heart Association class III heart failure. The plasma N-terminal pro-B-type natriuretic peptide (NT-pro BNP) level was 3691 pg/mL. The electrocardiogram (ECG) QRS complex (136 ms) was widened to 136 ms, with a left bundle branch block conturation (Fig. 1). The patient was being treated with spironolactone (aldactone), β-blocker (carvedilol), and angiotensin II receptor antagonist (captopril). Implantation of a cardiac resynchronization therapy defibrillator (CRT-D) was scheduled and performed in May 2011, without any complications. After implantation of the right ventricular (RV) lead in the RV apex, coronary venography was performed, and a suitable lateral branch was identified as a candidate vessel for left ventricular (LV) lead implantation. The LV lead was positioned at the midportion of the lateral branch. The LV pacing threshold was 0.5 mV at 0.5 ms without phrenic nerve stimulation. The right atrial (RA) lead was then positioned at the RA appendage. The following device and leads were used: Promote RF generator, Durata 7120Q RV defibrillation lead, QuickFlex 1158T LV lead, and Tendril STS RA lead (St. Jude Medical, St. Paul, Minnesota, USA). The RV pacing threshold was 0.75 V at 0.4 ms, and the RA pacing threshold was 0.5 V at 0.4 ms. The device was programmed with a ventricular tachycardia (VT) zone set to ≥166 bpm (therapies¼antitachy pacing (ATP) Â 3, shock 10 J, 25 J, 36 J Â 4) and a ventricular fibrillation (VF) zone set to ≥230 bpm (therapies¼ shock 15 J, 36 J, 36 J Â 4).After CRT-D implantation, the QRS duration decreased to 122 ms (Fig. 2), and the cardiac dyssynchrony improved. However, 5 days after implantation, atrial flutter (AFL) and electrical storm presenting as frequent VT were seen. As shown in Fig. 3A, the VT was initiated by a premature ventricular complex. The CRT-D i...